Alprostadil (FemLife Gel) in the Treatment of Female Sexual Arousal Disorder

Clinical trial NCT00572377 · TERMINATED

Trial details

NCT number: NCT00572377
Sponsor: Cedars-Sinai Medical Center
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Female Sexual Arousal Disorder

Start date: 2007-05-01
Primary completion: 2008-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.